Voyager Therapeutics (NASDAQ:VYGR) Given New $12.00 Price Target at Canaccord Genuity Group
Voyager Therapeutics (NASDAQ:VYGR – Free Report) had its price target trimmed by Canaccord Genuity Group from $14.00 to $12.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other equities analysts have also weighed in on VYGR. Citigroup initiated coverage on […]
Voyager Therapeutics (NASDAQ:VYGR – Free Report) had its price target trimmed by Canaccord Genuity Group from $14.00 to $12.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other equities analysts have also weighed in on VYGR. Citigroup initiated coverage on […]
